Camphor toxicity

Revision as of 01:35, 22 January 2016 by Kian (talk | contribs) (added reference)

Background

  • Common topical agent for pain relief, wart removal, osteoarthritis, cold sores
  • FDA limits over the counter preparations to 11%[1]
  • Highly lipophilic, widely and rapidly distributed

References

</reference>

  1. United States Food and Drug Administration. Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph. Fed Reg 1983